“…The shortage of β-glucuronidase in body tissues consequently results in proliferation of GAGs inside the lysosomes, leading to the enlargement of their size . As a consequence of over-expression of this enzyme in various cancers like the neoplasm of bladder, liver cancer, and colon carcinoma, , the quantitative measurement of β-glucuronidase has been proved as a detection tool at the initial stage diagnosis of cancer and the assessment of therapeutic treatments. , Moreover, it is evident from the literature that an elevated level of β-glucuronidase in blood serum is related to various physiological disorders such as urinary tract infection, rejection of transplantation, epilepsy, renal diseases, rheumatoid arthritis, and larynx and breast cancer . Besides these, acquired immune deficiency syndrome (AIDs) and hepatic disorders have also been reported as a consequence of a high level of this enzyme. , …”